Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: Yahoo! Finance
Tango Therapeutics extended its rally for a second day on Thursday to hit an all-time high, as investors took path from an investment firm's bullish stance for its stock. At intra-day trading, the stock climbed to its highest price of $16.97 before paring gains to finish the session just up by 36.28 percent at $16.83 apiece. medicine Photo by Pietro Jeng on Pexels In a market report, investment firm Stifel reaffirmed its “buy” recommendation and $15 price target for the stock. The figure was 21 percent higher than the $12.35 closing price in the previous trading day. This followed Tango Therapeutics Inc.'s (NASDAQ:TNGX) earnings performance last year, having narrowed its net loss by 22 percent to $101.59 million from $130.3 million in 2024. Total revenues also jumped by 48.3 percent to $62.38 million from $42.07 million year-on-year. In the fourth quarter alone, net loss widened by 26 percent to $38.7 million from $30.76 million, as it did not earn any revenues during the
Show less
Read more
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]Seeking Alpha
- Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business HighlightsGlobeNewswire
- Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $19.00 price target on the stock.MarketBeat
TNGX
Earnings
- 3/5/26 - Beat
TNGX
Sec Filings
- 3/5/26 - Form 144
- 3/5/26 - Form S-8
- 3/5/26 - Form 8-K
- TNGX's page on the SEC website